carbidopa and Chemical Dependence

carbidopa has been researched along with Chemical Dependence in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19903 (33.33)18.7374
1990's4 (44.44)18.2507
2000's1 (11.11)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Januário, C; Morgadinho, A; Reis Carneiro, D; Sousa, M1
Jasmin, L; Narasaiah, M; Tien, D1
Ellis, KL; Speed, J1
Heninger, GR; Kleber, HD; Kosten, TR; McDougle, CJ; Palumbo, JM; Price, LH1
Galante, M; Kokodoko, A; Mazzini, L; Rezzonico, M1
Angrist, B; Wolfsohn, R1
Flemenbaum, A; Rosen, H; Slater, VL1
Ballard, PA; Langston, JW; Tetrud, JW1
Nausieda, PA1

Other Studies

9 other study(ies) available for carbidopa and Chemical Dependence

ArticleYear
Dopamine dysregulation syndrome induced by proxy.
    BMJ case reports, 2019, May-16, Volume: 12, Issue:5

    Topics: Aged; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Substance-Related Disorders; Syndrome

2019
Noradrenaline is necessary for the hedonic properties of addictive drugs.
    Vascular pharmacology, 2006, Volume: 45, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Appetitive Behavior; Benzazepines; Biphenyl Compounds; Bupropion; Carbidopa; Cocaine; Dopamine beta-Hydroxylase; Dopamine Uptake Inhibitors; Droxidopa; Female; Genotype; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Morphine; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Norepinephrine; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D1; Reward; Substance-Related Disorders

2006
Pharmacologic management of movement disorder after midbrain haemorrhage.
    Brain injury, 1998, Volume: 12, Issue:7

    Topics: Activities of Daily Living; Adult; Brain Neoplasms; Carbidopa; Cavernous Sinus; Central Nervous System Stimulants; Cerebral Hemorrhage; Dopamine Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hemangioma, Cavernous; Humans; Levodopa; Male; Mesencephalon; Methamphetamine; Movement Disorders; Substance-Related Disorders

1998
Dopaminergic responsivity during cocaine abstinence: a pilot study.
    Psychiatry research, 1992, Volume: 43, Issue:1

    Topics: Adult; Carbidopa; Cocaine; Dopamine Agents; Drug Combinations; Growth Hormone; Homovanillic Acid; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prolactin; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders

1992
Methylbromide intoxication: a case report.
    Schweizer Archiv fur Neurologie und Psychiatrie (Zurich, Switzerland : 1985), 1992, Volume: 143, Issue:1

    Topics: Adult; Carbidopa; Clonazepam; Drug Therapy, Combination; Electroencephalography; Epilepsies, Myoclonic; Epilepsy, Tonic-Clonic; Evoked Potentials; Humans; Hydrocarbons, Brominated; Male; Myoclonus; Reaction Time; Substance-Related Disorders

1992
A pilot trial of levodopa/carbidopa in early cocaine abstinence.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:6

    Topics: Adult; Arousal; Carbidopa; Cocaine; Drug Therapy, Combination; Humans; Levodopa; Pilot Projects; Substance Withdrawal Syndrome; Substance-Related Disorders

1990
Clinical trial of carbidopa-L-dopa combination for cocaine abuse.
    The American journal of psychiatry, 1986, Volume: 143, Issue:11

    Topics: Carbidopa; Cocaine; Drug Therapy, Combination; Humans; Levodopa; Substance-Related Disorders

1986
Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.
    Neurology, 1985, Volume: 35, Issue:7

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acute Disease; Adult; Carbidopa; Chronic Disease; Drug Combinations; Female; Humans; Levodopa; Male; Parkinson Disease; Pyridines; Substance-Related Disorders; Substantia Nigra

1985
Sinemet "abusers".
    Clinical neuropharmacology, 1985, Volume: 8, Issue:4

    Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Self Administration; Substance-Related Disorders

1985